 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
1 October 1995 | Volume 123 Issue 7 | Pages 518-527
Objective: To quantify the protective efficacy of influenza vaccine in elderly persons.
Data Sources: A MEDLINE search was done using the index terms influenza vaccine, vaccine efficacy, elderly, mortality, hospitalized, and pneumonia. Appropriate references in the initially selected articles were also reviewed.
Study Selection: Only cohort observational studies with mortality assessment were included in the meta-analysis. In addition, 3 recent case–control studies, 2 cost-effectiveness studies, and 1 randomized, double-blind, placebo-controlled trial were reviewed.
Data Extraction: Vaccine and epidemic virus strains, age and sex of patients, severity of illness, patient status, and study design were recorded. Upper respiratory illness, hospitalization, pneumonia, and mortality were used as outcome measures.
Data Synthesis: In a meta-analysis of 20 cohort studies, the pooled estimates of vaccine efficacy (1 –odds ratio) were 56% (95% CI, 39% to 68%) for preventing respiratory illness, 53% (CI, 35% to 66%) for preventing pneumonia, 50% (CI, 28% to 65%) for preventing hospitalization, and 68% (CI, 56% to 76%) for preventing death.
Vaccine efficacy in the case–control studies ranged from 32% to 45% for preventing hospitalization for pneumonia, from 31% to 65% for preventing hospital deaths from pneumonia and influenza, from 43% to 50% for preventing hospital deaths from all respiratory conditions, and from 27% to 30% for preventing deaths from all causes. The randomized, double-blind, placebo-controlled trial showed a 50% or greater reduction in influenza-related illness. Recent cost-effectiveness studies confirm the efficacy of influenza vaccine in reducing influenza-related morbidity and mortality and show that vaccine provides important cost savings per year per vaccinated person.
Conclusion: Despite the paucity of randomized trials, many studies confirm that influenza vaccine reduces the risks for pneumonia, hospitalization, and death in elderly persons during an influenza epidemic if the vaccine strain is identical or similar to the epidemic strain. Influenza immunization is an indispensable part of the care of persons 65 years of age and older. Annual vaccine administration requires the attention of all physicians and public health organizations.
Author and Article Information
From Hackensack Medical Center, Hackensack, New Jersey; New Jersey Medical School, Newark, New Jersey; Mt. Sinai Medical Center, New York, New York; Tufts-New England Medical Center, Boston, Massachusetts; and the Food and Drug Administration, Bethesda, Maryland.
REVIEW
The Efficacy of Influenza Vaccine in Elderly Persons
A Meta-Analysis and Review of the Literature
Acknowledgments: The authors thank Mark Solomon for manuscript preparation and Duressa Pujat for reference services.
Grant Support: In part by the Center for Biologics Evaluation and Research, Food and Drug Administration, Contract 223-90-1102.
Requests for Reprints: Peter A. Gross, MD, Department of Internal Medicine, Hackensack Medical Center, 30 Prospect Avenue, Hackensack, NJ 07601.
Current Author Addresses: Dr. Gross: Department of Internal Medicine, Hackensack Medical Center, 30 Prospect Avenue, Hackensack, NJ 07601.
This article has been cited by other articles:
|
|
 |
|
  R. G. Masterton, A. Galloway, G. French, M. Street, J. Armstrong, E. Brown, J. Cleverley, P. Dilworth, C. Fry, A. D. Gascoigne, et al. Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy J. Antimicrob. Chemother., April 29, 2008; (2008) dkn162v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. C. Clayton, M. Thompson, and T. W. Meade Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database Eur. Heart J., January 1, 2008; 29(1): 96 - 103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. S. C. Jansen, E. A. M. Sanders, A. W. Hoes, A. M. van Loon, and E. Hak Influenza- and respiratory syncytial virus-associated mortality and hospitalisations Eur. Respir. J., December 1, 2007; 30(6): 1158 - 1166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. F. Antunes, E. A. Waldman, C. Borrell, and T. M. Paiva Effectiveness of influenza vaccination and its impact on health inequalities Int. J. Epidemiol., December 1, 2007; 36(6): 1319 - 1326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Zheng, Y. Zhang, H. He, E. Marinova, K. Switzer, D. Wansley, I. Mbawuike, and S. Han Rectification of Age-Associated Deficiency in Cytotoxic T Cell Response to Influenza A Virus by Immunization with Immune Complexes J. Immunol., November 1, 2007; 179(9): 6153 - 6159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Nichol, J. D. Nordin, D. B. Nelson, J. P. Mullooly, and E. Hak Effectiveness of Influenza Vaccine in the Community-Dwelling Elderly N. Engl. J. Med., October 4, 2007; 357(14): 1373 - 1381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Menendez and A. Torres Treatment Failure in Community-Acquired Pneumonia Chest, October 1, 2007; 132(4): 1348 - 1355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ortqvist, F. Granath, J. Askling, and J. Hedlund Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area Eur. Respir. J., September 1, 2007; 30(3): 414 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. de Andres, P. C. Garrido, V. Hernandez-Barrera, S. V.-F. del Pozo, A. G. de Miguel, and R. Jimenez-Garcia Influenza vaccination among the elderly Spanish population: trend from 1993 to 2003 and vaccination-related factors* Eur J Public Health, June 1, 2007; 17(3): 272 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Kimura, C. N. Nguyen, J. I. Higa, E. L. Hurwitz, and D. J. Vugia The Effectiveness of Vaccine Day and Educational Interventions on Influenza Vaccine Coverage Among Health Care Workers at Long-Term Care Facilities Am J Public Health, April 1, 2007; 97(4): 684 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Doe, S. Pathare, C. A. Kelly, C. R. Heycock, J. Binding, and J. Hamilton Uptake of influenza vaccination in patients on immunosuppressant agents for rheumatological diseases: a follow-up audit of the influence of secondary care Rheumatology, April 1, 2007; 46(4): 715 - 716. [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Spaude, E. Abrutyn, C. Kirchner, A. Kim, J. Daley, and D. N. Fisman Influenza Vaccination and Risk of Mortality Among Adults Hospitalized With Community-Acquired Pneumonia Arch Intern Med, January 8, 2007; 167(1): 53 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. G. Voordouw, M. C. J. M. Sturkenboom, J. P. Dieleman, T. Stijnen, J. van der Lei, and B. H. C. Stricker Annual influenza vaccination in community-dwelling elderly individuals and the risk of lower respiratory tract infections or pneumonia. Arch Intern Med, October 9, 2006; 166(18): 1980 - 1985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Gorse, T. Z. O'Connor, S. L. Young, M. P. Habib, J. Wittes, K. M. Neuzil, and K. L. Nichol Impact of a Winter Respiratory Virus Season on Patients With COPD and Association With Influenza Vaccination. Chest, October 1, 2006; 130(4): 1109 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Zoeteweij, D. E. Epperson, J. D. Porter, C. X. Zhang, O. Y. Frolova, A. P. Constantinides, S. R. Fuhrmann, M. El-Amine, J.-H. Tian, L. R. Ellingsworth, et al. GM1 Binding-Deficient Exotoxin Is a Potent Noninflammatory Broad Spectrum Intradermal Immunoadjuvant J. Immunol., July 15, 2006; 177(2): 1197 - 1207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Holvast, A Huckriede, J Wilschut, G Horst, J J C De Vries, C A Benne, C G M Kallenberg, and M Bijl Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease Ann Rheum Dis, July 1, 2006; 65(7): 913 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P Currie and J G. Douglas Non-pharmacological management. BMJ, June 10, 2006; 332(7554): 1379 - 1381. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Doyle, I. Bonmarin, D. Levy-Bruhl, Y. L. Strat, and J.-C. Desenclos Influenza pandemic preparedness in France: modelling the impact of interventions J. Epidemiol. Community Health, May 1, 2006; 60(5): 399 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. PAWELEC, S. KOCH, C. FRANCESCHI, and A. WIKBY Human immunosenescence: does it have an infectious component? Ann. N.Y. Acad. Sci., May 1, 2006; 1067: 56 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Link, I. B. Ahluwalia, G. L. Euler, C. B. Bridges, S. Y. Chu, and P. M. Wortley Racial and Ethnic Disparities in Influenza Vaccination Coverage among Adults during the 2004-2005 Season Am. J. Epidemiol., March 15, 2006; 163(6): 571 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Barnes and C. Quigley Flu vaccination in nursing homes: a survey of nursing-home managers J. Public Health Med., March 1, 2006; 28(1): 56 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chalmers Double-blind peer reviewed paper The role of healthcare workers in influenza prevention: Part one British Journal of Infection Control, February 1, 2006; 7(1): 16 - 20. [Abstract] [PDF]
|
|
|
|
|
|
T. Gluck Vaccinate your immunocompromised patients! Rheumatology, January 1, 2006; 45(1): 9 - 10. [Full Text] [PDF]
|
|
|
|
|
|
M. Woodhead, F. Blasi, S. Ewig, G. Huchon, M. Leven, A. Ortqvist, T. Schaberg, A. Torres, G. van der Heijden, and T. J. M. Verheij Guidelines for the management of adult lower respiratory tract infections Eur. Respir. J., December 1, 2005; 26(6): 1138 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. W. Thompson, D. K. Shay, E. Weintraub, L. Brammer, N. J. Cox, and K. Fukuda Influenza Vaccination Among the Elderly in the United States Arch Intern Med, September 26, 2005; 165(17): 2038 - 2039. [Full Text] [PDF]
|
|
|
|
|
|
P.-J. Lu, J. A. Singleton, M. C. Rangel, P. M. Wortley, and C. B. Bridges Influenza Vaccination Trends Among Adults 65 Years or Older in the United States, 1989-2002 Arch Intern Med, September 12, 2005; 165(16): 1849 - 1856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Gardner Caloric Restriction Decreases Survival of Aged Mice in Response to Primary Influenza Infection J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2005; 60(6): 688 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Wu, L. M. Wein, and A. S. Perelson Optimization of Influenza Vaccine Selection Operations Research, May 1, 2005; 53(3): 456 - 476. [Abstract] [PDF]
|
|
|
|
|
|
E. Hak, E. Buskens, G. A. van Essen, D. H. de Bakker, D. E. Grobbee, M. A. J. B. Tacken, B. A. van Hout, and T. J. M. Verheij Clinical Effectiveness of Influenza Vaccination in Persons Younger Than 65 Years With High-Risk Medical Conditions: The PRISMA Study Arch Intern Med, February 14, 2005; 165(3): 274 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. R. Dexter, S. M. Perkins, K. S. Maharry, K. Jones, and C. J. McDonald Inpatient Computer-Based Standing Orders vs Physician Reminders to Increase Influenza and Pneumococcal Vaccination Rates: A Randomized Trial JAMA, November 17, 2004; 292(19): 2366 - 2371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. G. Voordouw, M. C. J. M. Sturkenboom, J. P. Dieleman, Th. Stijnen, D. J. Smith, J. van der Lei, and B. H. Ch. Stricker Annual Revaccination Against Influenza and Mortality Risk in Community-Dwelling Elderly Persons JAMA, November 3, 2004; 292(17): 2089 - 2095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Menendez, A Torres, R Zalacain, J Aspa, J J Martin Villasclaras, L Borderias, J M Benitez Moya, J Ruiz-Manzano, F Rodriguez de Castro, J Blanquer, et al. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome Thorax, November 1, 2004; 59(11): 960 - 965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M Reilly The essence of EBM BMJ, October 30, 2004; 329(7473): 991 - 992. [Full Text] [PDF]
|
|
|
|
|
|
B. G Armstrong, P. Mangtani, A. Fletcher, S. Kovats, A. McMichael, S. Pattenden, and P. Wilkinson Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza: cohort study in elderly people BMJ, September 18, 2004; 329(7467): 660. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A Gross Postexposure prophylaxis with oseltamivir reduced influenza transmission in households Evid. Based Med., September 1, 2004; 9(5): 142 - 142. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Guebre-Xabier, S. A. Hammond, L. R. Ellingsworth, and G. M. Glenn Immunostimulant Patch Enhances Immune Responses to Influenza Virus Vaccine in Aged Mice J. Virol., July 15, 2004; 78(14): 7610 - 7618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Wongsurakiat, K. N. Maranetra, C. Wasi, U. Kositanont, W. Dejsomritrutai, and S. Charoenratanakul Acute Respiratory Illness in Patients With COPD and the Effectiveness of Influenza Vaccination: A Randomized Controlled Study Chest, June 1, 2004; 125(6): 2011 - 2020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. F. Dowell Surviving Pneumonia--Just a Short-Term Lease on Life? Am. J. Respir. Crit. Care Med., April 15, 2004; 169(8): 895 - 896. [Full Text] [PDF]
|
|
|
|
 |
|
 M. G Hudgens, P. B Gilbert, and S. G Self Endpoints in vaccine trials Statistical Methods in Medical Research, April 1, 2004; 13(2): 89 - 114. [Abstract] [PDF]
|
|
|
|
|
|
B. Christenson, J. Hedlund, P. Lundbergh, and A. Ortqvist Additive preventive effect of influenza and pneumococcal vaccines in elderly persons Eur. Respir. J., March 1, 2004; 23(3): 363 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Madjid, M. Naghavi, S. Litovsky, and S. W. Casscells Influenza and Cardiovascular Disease: A New Opportunity for Prevention and the Need for Further Studies Circulation, December 2, 2003; 108(22): 2730 - 2736. [Full Text]
|
|
|
|
|
|
L J Tata, J West, T Harrison, P Farrington, C Smith, and R Hubbard Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease? Thorax, October 1, 2003; 58(10): 835 - 839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Ford, D. M. Mannino, and S. G. Williams Asthma and Influenza Vaccination: Findings From the 1999-2001 National Health Interview Surveys Chest, September 1, 2003; 124(3): 783 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. G. Voordouw, P. D. van der Linden, S. Simonian, J. van der Lei, M. C. J. M. Sturkenboom, and B. H. C. Stricker Influenza Vaccination in Community-Dwelling Elderly: Impact on Mortality and Influenza-Associated Morbidity Arch Intern Med, May 12, 2003; 163(9): 1089 - 1094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Antonen, R. Pyhala, P. M. Hannula, I. O. Ala-Houhala, R. Santanen, N. Ikonen, and H. H. T. Saha Influenza vaccination of dialysis patients: cross-reactivity of induced haemagglutination-inhibiting antibodies to H3N2 subtype antigenic variants is comparable with the response of naturally infected young healthy adults Nephrol. Dial. Transplant., April 1, 2003; 18(4): 777 - 781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Ferguson, S. Mallett, H. Jackson, N. Roberts, and P. Ward A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals J. Antimicrob. Chemother., April 1, 2003; 51(4): 977 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Takahashi, Y. Noguchi, M. Rahman, T. Shimbo, M. Goto, K. Matsui, A. Asai, M. Onishi, H. Koyama, I. Sawada, et al. Influence of family on acceptance of influenza vaccination among Japanese patients Fam. Pract., April 1, 2003; 20(2): 162 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. W. Thompson, D. K. Shay, E. Weintraub, L. Brammer, N. Cox, L. J. Anderson, and K. Fukuda Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States JAMA, January 8, 2003; 289(2): 179 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Schwaiger, A. M. Wolf, P. Robatscher, B. Jenewein, and B. Grubeck-Loebenstein IL-4-Producing CD8+ T Cells with a CD62L++(bright) Phenotype Accumulate in a Subgroup of Older Adults and Are Associated with the Maintenance of Intact Humoral Immunity in Old Age J. Immunol., January 1, 2003; 170(1): 613 - 619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E Hak, T. J M Verheij, D E Grobbee, K L Nichol, and A W Hoes Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications J. Epidemiol. Community Health, December 1, 2002; 56(12): 951 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Bratzler, P. M. Houck, H. Jiang, W. Nsa, C. Shook, L. Moore, and L. Red Failure to Vaccinate Medicare Inpatients: A Missed Opportunity Arch Intern Med, November 11, 2002; 162(20): 2349 - 2356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Jackson, O. Yu, S. R. Heckbert, B. M. Psaty, D. Malais, W. E. Barlow, and W. W. Thompson Influenza Vaccination Is Not Associated with a Reduction in the Risk of Recurrent Coronary Events Am. J. Epidemiol., October 1, 2002; 156(7): 634 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. H. Menec, L. MacWilliam, and F. Y. Aoki Hospitalizations and Deaths Due to Respiratory Illnesses During Influenza Seasons: A Comparison of Community Residents, Senior Housing Residents, and Nursing Home Residents J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2002; 57(10): M629 - 635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Wouters-Wesseling, M. Rozendaal, M. Snijder, Y. Graus, G. Rimmelzwaan, L. de Groot, and J. Bindels Effect of a Complete Nutritional Supplement on Antibody Response to Influenza Vaccine in Elderly People J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2002; 57(9): M563 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-P. Humair, C. R. Buchs, and H. Stalder Promoting influenza vaccination of elderly patients in primary care Fam. Pract., August 1, 2002; 19(4): 383 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D P Weerasinghe, C R MacIntyre, and G L Rubin Seasonality of coronary artery deaths in New South Wales, Australia Heart, July 1, 2002; 88(1): 30 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Saurwein-Teissl, T. L. Lung, F. Marx, C. Gschosser, E. Asch, I. Blasko, W. Parson, G. Bock, D. Schonitzer, E. Trannoy, et al. Lack of Antibody Production Following Immunization in Old Age: Association with CD8+CD28- T Cell Clonal Expansions and an Imbalance in the Production of Th1 and Th2 Cytokines J. Immunol., June 1, 2002; 168(11): 5893 - 5899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A Gross Review: inactivated vaccines provide the greatest protection against influenza in healthy people Evid. Based Med., May 1, 2002; 7(3): 75 - 75. [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. Marshall, C. Henshaw, D. A. Evans, K. Bleyl, S. Alder, and T. G. Liou Influenza Vaccination Coverage Level at a Cystic Fibrosis Center Pediatrics, May 1, 2002; 109(5): e80 - 80. [Abstract] [Full Text] [PDF]
|
|
|
|
Article
